The agency reviewed data from the FELIX trial, in which 63 percent of patients achieved a complete remission on the cell therapy at any time point.

The University of Saskatchewan and University of Regina rivalry will take to the field for the Canada West championship this ...

Researchers say study offers proof-of-concept that targeting how T cells interact with metabolites in their environment can ...

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Exhausted T ...

CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells ...

Approval of the CD19 chimeric antigen receptor T-cell therapy (CAR T) — which, according to Autolus, was specifically “designed to have a ‘fast-off’ kinetic” to minimize excessive activation of the ...

Bharti says it isn’t clear what exactly caused the vision improvements. It’s possible that the transplanted cells themselves ...

Researchers from the Center for Regenerative Medicine (CReM) and the Department of Medicine at Boston Medical Center (BMC) ...

AbCellera (ABCL) announced new data on its T-cell engager, or TCE, platform, to be presented as a poster at the Society for Immunotherapy of ...